FDA
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
3 days ago
GenMark Diagnostics stock shot up on Friday after the company announced that the FDA has issued an Emergency Use Authorization for the company’s ePlex SARS-CoV-2 test.
13 days ago
Kala Pharmaceuticals said that it had positive topline results from its late-stage clinical trial for the treatment of dry eye disease.
24 days ago
Stealth Bio stock more than doubled on Tuesday after the company announced a critical update from the FDA.
30 days ago
Last Updated: 30 days ago
Co-Diagnostics is a small-cap stock that is far from a household name, but it has received much added exposure of late.
30 days ago
Karyopharm Therapeutics shares made a handy gain on Wednesday after the firm secured a key FDA nod for its relapsed or refractory diffuse large B-cell lymphoma treatment.
1 month ago
Agile Therapeutics shares took a dip on Tuesday after the company announced a key FDA approval for its new weekly contraceptive patch. Yet, one analyst sees great long-term potential, targeting the...
1 month ago
Aimmune Therapeutics shares jumped early on Monday after the FDA announced late Friday a critical approval for the firm’s peanut allergy treatment.
1 month ago
Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe to severe Alzheimer's disease patients.
2 months ago
Last Updated: 2 months ago
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from...
2 months ago
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
2 months ago
Last Updated: 2 months ago
Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.
2 months ago
Last Updated: 2 months ago
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
2 months ago
Last Updated: 2 months ago
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
2 months ago
Last Updated: 2 months ago
Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its seizure treatment.
2 months ago
Last Updated: 2 months ago